These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12833142)

  • 1. Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo.
    Baron V; De Gregorio G; Krones-Herzig A; Virolle T; Calogero A; Urcis R; Mercola D
    Oncogene; 2003 Jul; 22(27):4194-204. PubMed ID: 12833142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense to the early growth response-1 gene (Egr-1) inhibits prostate tumor development in TRAMP mice.
    Baron V; Duss S; Rhim J; Mercola D
    Ann N Y Acad Sci; 2003 Dec; 1002():197-216. PubMed ID: 14751836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent.
    Santiago FS; Atkins DG; Khachigian LM
    Am J Pathol; 1999 Sep; 155(3):897-905. PubMed ID: 10487847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.
    Huang RP; Darland T; Okamura D; Mercola D; Adamson ED
    Oncogene; 1994 May; 9(5):1367-77. PubMed ID: 8152797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense Egr-1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injury.
    Fahmy RG; Khachigian LM
    J Cell Biochem; 2002; 84(3):575-82. PubMed ID: 11813262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early growth response factor-1 mediates insulin-inducible vascular endothelial cell proliferation and regrowth after injury.
    Gousseva N; Kugathasan K; Chesterman CN; Khachigian LM
    J Cell Biochem; 2001; 81(3):523-34. PubMed ID: 11255235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis.
    de Belle I; Huang RP; Fan Y; Liu C; Mercola D; Adamson ED
    Oncogene; 1999 Jun; 18(24):3633-42. PubMed ID: 10380885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1.
    Liu C; Adamson E; Mercola D
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11831-6. PubMed ID: 8876223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of Egr-1 mediating VEGF-induced tissue factor expression in the retinal capillary endothelium.
    Sassa Y; Hata Y; Murata T; Yamanaka I; Honda M; Hisatomi T; Fujisawa K; Sakamoto T; Kubota T; Nakagawa K; Sueishi K; Ishibashi T
    Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):1003-10. PubMed ID: 12483323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of Egr-1 and NF-kappaB in the pathogenesis of silicosis: an in-vitro study].
    Niu HY; Zeng QF; Li X; Chu L; Hu YB; Wang JS
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):363-7. PubMed ID: 15363325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity.
    Liu C; Calogero A; Ragona G; Adamson E; Mercola D
    Crit Rev Oncog; 1996; 7(1-2):101-25. PubMed ID: 9109500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3.
    Parra E; Ortega A; Saenz L
    Oncol Rep; 2009 Dec; 22(6):1513-8. PubMed ID: 19885607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain.
    Huang RP; Liu C; Fan Y; Mercola D; Adamson ED
    Cancer Res; 1995 Nov; 55(21):5054-62. PubMed ID: 7585551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of alpha 2(I) collagen gene expression by fibroblast growth factor-2 in MC3T3-E1 osteoblast-like cells.
    Fang MA; Glackin CA; Sadhu A; McDougall S
    J Cell Biochem; 2001; 80(4):550-9. PubMed ID: 11169739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Egr-1 in vascular smooth muscle cell proliferation in response to allo-antigen.
    Wada Y; Fujimori M; Suzuki J; Tsukioka K; Ito K; Sawa Y; Morishita R; Kaneda Y; Isobe M; Amano J
    J Surg Res; 2003 Dec; 115(2):294-302. PubMed ID: 14697297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage.
    Nguyen HQ; Hoffman-Liebermann B; Liebermann DA
    Cell; 1993 Jan; 72(2):197-209. PubMed ID: 7678779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The zinc finger transcription factor EGR-1 impedes interleukin-1-inducible tumor growth arrest.
    Sells SF; Muthukumar S; Sukhatme VP; Crist SA; Rangnekar VM
    Mol Cell Biol; 1995 Feb; 15(2):682-92. PubMed ID: 7823937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and clinicopathologic study on the relationship between transcription factor Egr-1 and esophageal carcinoma.
    Wu MY; Chen MH; Liang YR; Meng GZ; Yang HX; Zhuang CX
    World J Gastroenterol; 2001 Aug; 7(4):490-5. PubMed ID: 11819815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis.
    Carl M; Akagi Y; Weidner S; Isaka Y; Imai E; Rupprecht HD
    Kidney Int; 2003 Apr; 63(4):1302-12. PubMed ID: 12631347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1.
    Liu C; Yao J; de Belle I; Huang RP; Adamson E; Mercola D
    J Biol Chem; 1999 Feb; 274(7):4400-11. PubMed ID: 9933644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.